PRKX and ovarian cancer: The latest research found that NRSN2-AS1 is significantly overexpressed in ovarian cancer, plays a tumor-promoting role as the sponge of miR-744-5p, and regulates the Wnt/β-catenin signaling pathway via the miR-744-5p/PRKX axis (48).